ID
11867
Description
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany
Link
https://clinicaltrials.gov/ct2/show/NCT02419378
Keywords
Versions (5)
- 8/13/15 8/13/15 - Martin Dugas
- 5/23/16 5/23/16 -
- 5/28/16 5/28/16 -
- 5/28/16 5/28/16 -
- 6/6/16 6/6/16 -
Uploaded on
August 13, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0 Legacy
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Recent Symptoms Multiple Sclerosis ALAIN01 NCT02419378
Recent Symptoms Multiple Sclerosis ALAIN01 NCT02419378
- StudyEvent: SE
Description
Relapse: Recent symptoms RQG
Description
Relapse: Recent symptoms description
Data type
text
Alias
- UMLS CUI [1]
- C1457887
Description
Relapse: Recent symptoms Start Date
Data type
date
Alias
- UMLS CUI [1,1]
- C1457887
- UMLS CUI [1,2]
- C2826738
Description
Relapse: Recent symptoms Start Date Status
Data type
text
Description
Relapse: Recent symptoms End Date
Data type
date
Alias
- UMLS CUI [1,1]
- C1457887
- UMLS CUI [1,2]
- C2826747
Description
Relapse: Recent symptoms End Date Status
Data type
text
Description
Relapse: Recent symptoms ongoing
Data type
text
Similar models
Recent Symptoms Multiple Sclerosis ALAIN01 NCT02419378
- StudyEvent: SE
C2826738 (UMLS CUI [1,2])
C2826747 (UMLS CUI [1,2])